These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 5619704)

  • 1. [Study of the antilipidogenic and hypolipidemic effects of Insoal in diabetics and atherosclerotics].
    Warembourg H; Jaillard J
    Lille Med; 1967 May; 12(4):Suppl:510-5. PubMed ID: 5619704
    [No Abstract]   [Full Text] [Related]  

  • 2. [Clinical experience with an antilipemic agent, ethylchlorophenoxyisobutyrate].
    Noleto PA; de Bulhões F; Tuma M
    Rev Bras Med; 1969 Oct; 26(10):602-5. PubMed ID: 5404870
    [No Abstract]   [Full Text] [Related]  

  • 3. [Therapeutic agents for lipid metabolism disorders--with special reference to arterial diseases].
    Murakami M; Sekimoto H; Nagai T; Nakata I; Takekoshi T
    Nihon Rinsho; 1970 Mar; 28 Suppl():696-9. PubMed ID: 5430846
    [No Abstract]   [Full Text] [Related]  

  • 4. [Effect of chlorophenoxy-isobutyric ester on platelet adhesiveness and aggregation in the patients with arteriosclerosis and diabetes mellitus].
    Yasunaga K
    Naika Hokan; 1969 Oct; 16(10):393-403. PubMed ID: 5391800
    [No Abstract]   [Full Text] [Related]  

  • 5. [Effect of phenethylbiguanide on body weight and some serum lipid indices in obese subjects, obese diabetics and obese subjects with potential diabetes].
    Pompei A; Marcenaro A; Foppiani E; Jacopino GE
    Clin Ter; 1969 Dec; 51(6):541-60. PubMed ID: 5371379
    [No Abstract]   [Full Text] [Related]  

  • 6. [Changes of the blood lipid pattern in diabetics under treatment with chlorpropamide and phenethyl-1-biguanide].
    Meduri D; Polito R
    Minerva Med; 1969 Jun; 60(49):2439-48. PubMed ID: 5802656
    [No Abstract]   [Full Text] [Related]  

  • 7. [Treatment of atherosclerosis with hypolipidemic and antiuricemic agents].
    Plastinina RA; Oleĭnik NA; Valeeva RM; Pavlova TN
    Sov Med; 1984; (1):83-7. PubMed ID: 6701660
    [No Abstract]   [Full Text] [Related]  

  • 8. [Arteriosclerosis with special reference to anticholesteremic agents].
    Murakami M; Sekimoto H; Nakada I; Takegoshi T; Iwaki N
    Naika; 1970 Jun; 25(6):1082-6. PubMed ID: 5431239
    [No Abstract]   [Full Text] [Related]  

  • 9. The effect on serum tocopherol levels of drug-induced decrease in serum lipids.
    Weiss P; Bianchine JR
    Am J Med Sci; 1969 Oct; 258(4):275-81. PubMed ID: 5823464
    [No Abstract]   [Full Text] [Related]  

  • 10. [Antilipidemic activity of ethyl-chloro-phenoxy-isobutyrate or clofibrate].
    Barisone D; Gallo G; Accardo S
    Minerva Med; 1969 Jan; 60(6):174-80. PubMed ID: 5776766
    [No Abstract]   [Full Text] [Related]  

  • 11. Role of mushroom (Pleurotus florida) as hypocholesterolemic/hypolipidemic agent.
    Khanna PK; Bhandari R; Soni GL; Singh CK; Garcha HS; Mittar D
    Indian J Exp Biol; 1993 Jun; 31(6):567-8. PubMed ID: 8406606
    [No Abstract]   [Full Text] [Related]  

  • 12. [Phenformin treatment of arteriosclerotic patients: changes induced in the plasma lipid picture. Preliminary note].
    Negri AU; Matteoli E; Zaini GF; Riva D
    Minerva Med; 1971 Nov; 62(89):4405-12. PubMed ID: 5162252
    [No Abstract]   [Full Text] [Related]  

  • 13. The effects of phenphormin on blood fibrinolysis in diabetes mellitus.
    Fiaschi E; Barbui T; Previato G; Di Luzio V; Guarnieri GF; Todesco S
    Arzneimittelforschung; 1969 Apr; 19(4):638-40. PubMed ID: 5819165
    [No Abstract]   [Full Text] [Related]  

  • 14. [Prescriptions for arteriosclerosis therapy].
    Fanelli Y
    Clin Ter; 1978 Mar; 84(6):641-7. PubMed ID: 648110
    [No Abstract]   [Full Text] [Related]  

  • 15. [Glibenclamide-phenformin in diabetics with failures after sulfonylureas].
    Garcia Viveros M; Prado R; Rull JA; Lozano-Castañeda O
    Prensa Med Mex; 1971 Dec; 36(11):522-5. PubMed ID: 5003829
    [No Abstract]   [Full Text] [Related]  

  • 16. [Action of instantaneous-delayed action phenformin, alone or in combined therapy, in 50 hospitalized diabetics].
    Vague J; Vague P; Jaquet P; Gerolami G
    Mars Med; 1966; 103(4):331-3. PubMed ID: 5997802
    [No Abstract]   [Full Text] [Related]  

  • 17. [Effect of ethyl alpha-p-chlorophenoxyisobutyrate (Clofibrate) on lipids, cholesterol and uric acid in diabetes mellitus].
    Orsetti A; Mirouze J
    Therapie; 1966; 21(3):685-91. PubMed ID: 5942133
    [No Abstract]   [Full Text] [Related]  

  • 18. [Effect of clofibrate on serum lipids in atherosclerosis].
    Gietz E
    Med Klin; 1967 Mar; 62(9):336-8 passim. PubMed ID: 5593571
    [No Abstract]   [Full Text] [Related]  

  • 19. [Further data on the use of a preparation with antisclerotic action in geriatrics].
    Solaro F; Zinnari A; Dinale M
    G Gerontol; 1970 Mar; 18(3):177-84. PubMed ID: 5473220
    [No Abstract]   [Full Text] [Related]  

  • 20. [Drug therapy of high risk patients with diabetes mellitus].
    Krone W; Müller-Wieland D
    Verh Dtsch Ges Inn Med; 1991; 97():238-42. PubMed ID: 1808892
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.